X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

Content Team by Content Team
13th July 2022
in Packaging & Logistic, Press Statements
DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

DoKaSch Temperature Solutions and Japan Airlines (JAL) have signed a new Master Rental Agreement (MRA) for the usage of the temperature- controlled Opticooler as part of the cool service of the Japanese major carrier. The MRA opens up new possibilities to use the active Opticooler as a reliable and capable supply chain solution for pharmaceutical shipments to and from Asia. Therefore, DoKaSch and JAL meet the country’s growing needs for vaccine and pharmaceutical transportation in a safe and reliable way.

At Narita International Airport, Japan Airlines operates a hub at an airport that handles about 60% of Japan’s total pharmaceutical import trade. Furthermore, JAL’s intercontinental networks connect Japan with major hubs in Europe, North America, China, Southeast Asia as well as Australia. The new Master Rental Agreement with DoKaSch Temperature Solutions enables Japan Airlines to strengthen its cool chain capacities for its safe and fast pharma service providing forwarders and pharma producers with highly reliable packaging solutions. This makes Japan Airlines an important partner for the global supply of pharmaceutical products.

The Opticooler is a temperature-controlled packaging solution and comes in two sizes: the RAP container hold up to five euro-pallets, while the smaller RKN version provides space for one euro-pallet. Both active containers are battery-powered, can easily be adapted to any transport scenario, and enable customers to always keep the desired temperature level for example between two and eight degrees at any given time. Since the Opticoolers only require a power socket to be charged, they can easily be used as temporary storage when the necessary cool infrastructure is lacking. This makes them the ideal solution for the safe transport of highly sensitive pharmaceutical products which need to be protected from temperature deviations at all times.

Kiyoaki Yasui, Team leader, Cold Chain Logistics Team, of Japan Airlines stresses the importance of the agreement: “We have always focused on a strong cool chain within our network because the supply of lifesaving medicines is absolutely crucial. Thanks to direct connections to some of the most important hubs in Narita and Haneda, we can provide highly reliable and quick transports to a wide variety of destinations. The Opticoolers provided by DoKaSch Temperature Solutions are fulfilling our high standards and will support our extensive cool chain network in the Asia-Pacific region and beyond.”

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, adds: “The new Master Rental Agreement with Japan Airlines is an important addition to our partner network and significantly increases the availability of our Opticoolers in the Asia-Pacific region. Since especially Japan is an important producer of pharmaceutical products, reliable cool chain capacities in the greater region are of great importance. By providing our Opticoolers for these routes, we are able to support the supply with lifesaving medicines in the region as well as worldwide.”

Previous Post

Lonza To Construct $518mn Fill-Finish Plant In Switzerland

Next Post

Indian Pharma Business May Increase 8-11%, Predicts Alkem

Related Posts

Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Press Statements

Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East

11th December 2024
Press Statements

Pharma Contract Manufacturing 2025

7th December 2024
Press Statements

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

18th November 2024
Next Post
Indian Pharma Business May Increase 8-11%, Predicts Alkem

Indian Pharma Business May Increase 8-11%, Predicts Alkem

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In